FOLLOW US

  • facebook
  • twitter
Thu

March 11, 2026

Eli Lilly to acquire Adverum Biotechnologies

America October 24, 2025

Eli Lilly to Acquire Adverum Biotechnologies

Pharmaceutical powerhouse Eli Lilly and Co. announced Friday that it will acquire Adverum Biotechnologies, a clinical-stage gene therapy innovator targeting…

By Rihem Akkouche

Pfizer to acquire Metsera

America September 22, 2025

Pfizer to Acquire Metsera in $4.9B Bet on Obesity and Cardiometabolic Therapies

Pfizer Inc. is making a daring return to the obesity battlefield, announcing Monday that it will acquire Metsera Inc. for…

By Rihem Akkouche

Eli Lilly $1.3B deal

America August 14, 2025

Eli Lilly Strikes $1.3B Superluminal Deal to Tackle Obesity and Cardiometabolic Diseases

In a move poised to shake the pharmaceutical landscape, Eli Lilly & Co. has inked a deal worth up to…

By Rihem Akkouche

Eli Lilly bamlanivimab

Business November 10, 2020

FDA grants Eli Lilly emergency use authorization for bamlanivimab treatment for COVID-19

The U.S. Food and Drug Administration (FDA) granted Eli Lilly and Company (NYSE: LLY) an emergency use authorization (EUA) for…

By Marivic Cabural Summers

Signup for the USA Herald
exclusive Newsletter